Use of contrast enhanced ultrasound in testicular diseases: A comprehensive review.


Journal

Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129

Informations de publication

Date de publication:
09 2021
Historique:
revised: 12 05 2021
received: 28 03 2021
accepted: 24 05 2021
pubmed: 28 5 2021
medline: 25 2 2022
entrez: 27 5 2021
Statut: ppublish

Résumé

Contrast-enhanced ultrasound (CEUS) is a sonographic technique that increases the diagnostic accuracy of ultrasound and color Doppler ultrasound (CDUS) when studying testicular abnormalities. However, its role in clinical practice is still debatable because there are no accepted standards regarding how and when this technique should be used for patients with testicular disease. To perform a nonsystematic review of the current literature to highlight the strength and flaws of performing CEUS and to provide a critical overview of current research evidence on this topic. A thorough search of published peer-reviewed studies in PubMed was performed using proper keywords. Strong enhancement of neoplastic lesions (both benign and malignant) during CEUS aids in differential diagnosis with non-neoplastic lesions, which usually appears either nonenhanced or enhanced in a manner similar to that of the surrounding parenchyma. CEUS enhancement has a high predictive value in the identification of neoplastic lesions, whereas a similar or complete absence of enhancement may be interpreted as strong evidence of benignity, although there are exceptions. Literature on quantitative analysis is still scarce, though promising, particularly in distinguishing benign from malignant neoplasms. Furthermore, CEUS may be useful in many emergency situations, such as acute scrotum, blunt scrotal trauma, and focal infarction of the testis. Finally, CEUS can help increase the probability of sperm recovery in azoospermic males. CEUS is a safe, easy-to-perform, and cost-effective diagnostic tool that can provide a more accurate diagnosis in testicular lesions and acute scrotal disease. However, further studies with larger cohorts are required to refine the differential diagnosis between benign and malignant neoplasms. Finally, these preliminary results can instigate the development of innovative research on pre-testicular sperm extraction to increase the chances of sperm recovery.

Sections du résumé

BACKGROUND
Contrast-enhanced ultrasound (CEUS) is a sonographic technique that increases the diagnostic accuracy of ultrasound and color Doppler ultrasound (CDUS) when studying testicular abnormalities. However, its role in clinical practice is still debatable because there are no accepted standards regarding how and when this technique should be used for patients with testicular disease.
OBJECTIVES
To perform a nonsystematic review of the current literature to highlight the strength and flaws of performing CEUS and to provide a critical overview of current research evidence on this topic.
MATERIALS AND METHODS
A thorough search of published peer-reviewed studies in PubMed was performed using proper keywords.
RESULTS
Strong enhancement of neoplastic lesions (both benign and malignant) during CEUS aids in differential diagnosis with non-neoplastic lesions, which usually appears either nonenhanced or enhanced in a manner similar to that of the surrounding parenchyma. CEUS enhancement has a high predictive value in the identification of neoplastic lesions, whereas a similar or complete absence of enhancement may be interpreted as strong evidence of benignity, although there are exceptions. Literature on quantitative analysis is still scarce, though promising, particularly in distinguishing benign from malignant neoplasms. Furthermore, CEUS may be useful in many emergency situations, such as acute scrotum, blunt scrotal trauma, and focal infarction of the testis. Finally, CEUS can help increase the probability of sperm recovery in azoospermic males.
DISCUSSION AND CONCLUSION
CEUS is a safe, easy-to-perform, and cost-effective diagnostic tool that can provide a more accurate diagnosis in testicular lesions and acute scrotal disease. However, further studies with larger cohorts are required to refine the differential diagnosis between benign and malignant neoplasms. Finally, these preliminary results can instigate the development of innovative research on pre-testicular sperm extraction to increase the chances of sperm recovery.

Identifiants

pubmed: 34043256
doi: 10.1111/andr.13057
pmc: PMC8640938
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1369-1382

Informations de copyright

© 2021 American Society of Andrology and European Academy of Andrology.

Références

Ultrasound. 2016 Feb;24(1):23-33
pubmed: 27433272
J Ultrasound Med. 2015 Jul;34(7):1319-28
pubmed: 26112637
Radiographics. 2002 Jan-Feb;22(1):189-216
pubmed: 11796908
Medicine (Baltimore). 2018 Sep;97(37):e12390
pubmed: 30213007
J Ultrasound Med. 2019 Sep;38(9):2417-2425
pubmed: 30680779
J Clin Endocrinol Metab. 2004 Aug;89(8):4078-88
pubmed: 15292351
Andrology. 2016 Nov;4(6):1193-1203
pubmed: 27565451
Ultrasound Med Biol. 2006 Sep;32(9):1369-75
pubmed: 16965977
Clin Hemorheol Microcirc. 2019;73(2):347-357
pubmed: 31156146
Radiographics. 2017 Jul-Aug;37(4):1085-1098
pubmed: 28574809
Syst Biol Reprod Med. 2020 Feb;66(1):70-75
pubmed: 31687848
Eur Radiol. 2012 Apr;22(4):721-30
pubmed: 22028111
Transl Androl Urol. 2021 Feb;10(2):562-573
pubmed: 33718059
Urol Case Rep. 2020 Apr 01;31:101168
pubmed: 32280595
Clin Radiol. 2018 Mar;73(3):322.e1-322.e9
pubmed: 29122221
Ultraschall Med. 2012 Feb;33(1):33-59
pubmed: 21874631
Ultraschall Med. 2019 Apr;40(2):253-254
pubmed: 30776833
J Ultrasound. 2015 Nov 27;19(1):35-9
pubmed: 26941881
Br J Radiol. 2012 Nov;85 Spec No 1:S41-53
pubmed: 22674702
Ultraschall Med. 2012 Oct;33(5):409-410
pubmed: 22623134
J Ultrasound. 2014 May 31;17(3):233-8
pubmed: 25177399
Front Pharmacol. 2019 Dec 05;10:1447
pubmed: 31866865
Andrology. 2020 Sep;8(5):1051-1063
pubmed: 32445591
Ultraschall Med. 2020 Dec;41(6):668-674
pubmed: 31597180
Eur Radiol. 2018 Feb;28(2):554-564
pubmed: 28856410
BJU Int. 2006 Nov;98(5):1001-4
pubmed: 16956359
Hum Reprod. 2019 Aug 1;34(8):1389-1403
pubmed: 31532522
J Clin Med. 2020 Feb 21;9(2):
pubmed: 32098148
Am J Emerg Med. 2018 Dec;36(12):2339.e1-2339.e3
pubmed: 30243701
Fertil Steril. 2007 May;87(5):1071-6
pubmed: 17173898
J Urol. 1989 Jul;142(1):62-5
pubmed: 2499695
Eur Radiol. 2015 Dec;25(12):3586-95
pubmed: 25981218
Eur Radiol. 2016 Jul;26(7):2268-78
pubmed: 26497666
Int J Androl. 2009 Oct;32(5):524-31
pubmed: 18498357
Nat Rev Urol. 2013 Mar;10(3):135-48
pubmed: 23338520
Ultraschall Med. 2019 Oct;40(5):618-624
pubmed: 30895585
Ultraschall Med. 2016 Apr;37(2):201-5
pubmed: 25607628
J Ultrasound Med. 2012 Jan;31(1):115-22
pubmed: 22215776
Br J Radiol. 2012 Mar;85(1011):e65-8
pubmed: 22391504
Eur J Radiol. 2016 Mar;85(3):649-56
pubmed: 26860680
Radiology. 2017 Nov;285(2):640-649
pubmed: 28628420
Eur Radiol. 2005 May;15(5):941-5
pubmed: 15662495
J Ultrasound Med. 2019 Jul;38(7):1847-1854
pubmed: 30548880
Hepatol Res. 2012 Apr;42(4):376-84
pubmed: 22221694
Ultraschall Med. 2014 Dec;35(6):534-9
pubmed: 25140496
Hum Reprod Update. 2017 May 1;23(3):265-275
pubmed: 28379559
BJU Int. 2011 Nov;108(10):1603-7
pubmed: 21631694
Am Fam Physician. 2013 Dec 15;88(12):835-40
pubmed: 24364548
Radiology. 2012 May;263(2):584-9
pubmed: 22396607
Scand J Urol. 2020 Jun;54(3):241-247
pubmed: 32449437
Asian J Androl. 2021 Jan-Feb;23(1):59-63
pubmed: 32341210
J Assist Reprod Genet. 2004 May;21(5):175-80
pubmed: 15279325
Eur Urol. 2010 May;57(5):780-90
pubmed: 20116165
BMC Urol. 2019 Jun 11;19(1):52
pubmed: 31185974
Eur J Radiol. 2015 Sep;84(9):1675-84
pubmed: 26014102
J Ultrasound. 2011 Dec;14(4):188-95
pubmed: 23396988
AJR Am J Roentgenol. 2011 Apr;196(4):834-41
pubmed: 21427332
Int Braz J Urol. 2009 Nov-Dec;35(6):692-702; discussion 702-5
pubmed: 20028575
Arch Ital Urol Androl. 2014 Dec 30;86(4):378-82
pubmed: 25641475
J Ultrasound Med. 2016 Jul;35(7):1593-9
pubmed: 27335443
Eur Radiol. 2001;11(2):220-8
pubmed: 11218018
Radiol Med. 2012 Oct;117(7):1161-75
pubmed: 22327925
Ultrasound Med Biol. 2016 Aug;42(8):1807-15
pubmed: 27181687
J Ultrasound Med. 2017 Mar;36(3):531-538
pubmed: 28072475
Case Rep Radiol. 2019 Dec 28;2019:7568098
pubmed: 31956462
Eur Radiol. 2011 Sep;21(9):1831-40
pubmed: 21633826
Andrology. 2021 Sep;9(5):1369-1382
pubmed: 34043256
Histopathology. 2017 Feb;70(3):335-346
pubmed: 27747907
BMC Urol. 2018 May 23;18(1):48
pubmed: 29792185
Radiology. 2003 Apr;227(1):18-36
pubmed: 12616012
Ultraschall Med. 2016 Dec;37(6):619-626
pubmed: 27300274
Andrology. 2021 Mar;9(2):559-576
pubmed: 33244893
AJR Am J Roentgenol. 2012 Sep;199(3):W345-54
pubmed: 22915425
J Ultrasound. 2021 Jan 6;:
pubmed: 33409864
Urology. 2021 Aug;154:16-23
pubmed: 33621585
J Surg Oncol. 2018 Sep;118(4):630-635
pubmed: 30196556
Echo Res Pract. 2015 Jun 1;2(2):R55-62
pubmed: 26693339
Radiology. 2014 Nov;273(2):606-18
pubmed: 24968192
Nat Rev Urol. 2013 Dec;10(12):703-12
pubmed: 24217678
Medicine (Baltimore). 2019 Mar;98(11):e14779
pubmed: 30882650
Eur Radiol. 2007 Nov;17(11):2810-8
pubmed: 17611760
Urology. 2011 May;77(5):1049-53
pubmed: 21334049
AJR Am J Roentgenol. 2019 Feb 26;:1-6
pubmed: 30807223
Andrology. 2020 Sep;8(5):1214-1221
pubmed: 32374923
Ultraschall Med. 2018 Apr;39(2):e2-e44
pubmed: 29510439
BJU Int. 2018 Apr;121(4):575-582
pubmed: 29032579
Leuk Lymphoma. 2018 Nov;59(11):2622-2627
pubmed: 29486623

Auteurs

Marta Tenuta (M)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Franz Sesti (F)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Ilaria Bonaventura (I)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Paola Mazzotta (P)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Riccardo Pofi (R)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Daniele Gianfrilli (D)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Carlotta Pozza (C)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH